1.
Thaçi D, Lebwohl M, Warren RB, Kircik L, Banerjee S, Napoli A, Kisa RM, Linaberry M, Hoyt K, Blauvelt A. Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s243. Available from: https://jofskin.org/33014/index.php/skin/article/view/2358